TRIM21 and autoimmune disease: Given the pathogenic role of dysregulated cGAS-STING signaling in autoimmune disorders, targeting TRIM21’s E3 ubiquitin ligase activity could open new avenues for developing precision therapeutics to modulate this pathway in SLE and related conditions.